Insider trades › Pfizer · Pfizer company page
Pfizer insider trading
Transactions in PFE stock reported by Pfizer executives, directors and large holders on SEC Form 4 over the last 120 days. Last update 2026-10-14.
$83Kopen-market sales (3,278 shares, 1 insiders)
$3.0Mopen-market purchases (114,863 shares, 3 insiders)
25Form 4 filings
Insiders
Albert Bourla Chairman & CEO, Director Bought $1.0M Ronald E Blaylock Director Bought $999K Mortimer J Buckley Director Bought $960K Jennifer B. Damico SVP & Controller Sold $83K
All transactions
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Albert Bourla Chairman & CEO, Director | Open-market purchase | 38,000 | $26.34 | $1.0M | Form 4 ↗ |
| Aug 5, 2026 | Jennifer B. Damico SVP & Controller | Open-market sale | 3,278 | $25.40 | $83K | Form 4 ↗ |
| Aug 5, 2026 | Ronald E Blaylock Director | Open-market purchase | 39,231 | $25.46 | $999K | Form 4 ↗ |
| Aug 5, 2026 | Mortimer J Buckley Director | Open-market purchase | 37,632 | $25.52 | $960K | Form 4 ↗ |
Source: SEC EDGAR, Pfizer Form 4 filings. Values are shares × reported price for open-market trades. Insider trades are reported facts, not recommendations. Not investment advice. See the tracker for how to read the codes.